Bottom line
XBI vs FBIOX: the short answer
XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and FBIOX (Biotechnology Portfolio) are quite different portfolios: only about 20% of their top holdings (by weight) are shared.
XBI is cheaper at 0.35% vs 0.62% — a difference of $27 a year per $10,000 invested.
Over five years, FBIOX returned +3.5% a year vs −2.7% for XBI (reporting dates differ).
Updated Nov 19, 2026
XBI vs FBIOX side by side
| XBI | FBIOX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | SPDR (State Street) | Fidelity |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.35% | 0.62% |
| Annual cost per $10k | $35 | $62 |
| 10-yr cost on $10k (prospectus) | $443 | $774 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +35.8% | +36.4% |
| 5-yr return (annualized) | −2.7% | +3.5% |
| 10-yr return (annualized) | +5.8% | +6.9% |
| Best quarter | +44.4% | +33.6% |
| Worst quarter | −26.2% | −28.4% |
| Net assets (fund) | $10.7B | $5.3B |
| Number of holdings | 161 | 215 |
| Portfolio turnover | 71% | 45% |
| Returns as of | Dec 31, 2025 | Apr 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | XBI | FBIOX | Difference |
|---|---|---|---|
| 2025 | +35.8% | +36.4% | −0.5% |
| 2024 | +1.1% | +7.3% | −6.2% |
| 2023 | +7.5% | +10.1% | −2.6% |
| 2022 | −25.8% | −15.9% | −9.9% |
| 2021 | −20.5% | −12.4% | −8.2% |
| 2020 | +48.2% | +38.3% | +9.8% |
| 2019 | +32.2% | +36.0% | −3.8% |
| 2018 | −14.9% | −10.7% | −4.2% |
| 2017 | +43.7% | +27.9% | +15.8% |
| 2016 | −15.4% | −23.7% | +8.3% |
Source: Fund prospectus bar charts
Holdings overlap
8 of XBI's top 25 holdings also appear in FBIOX's top 25.
| Holding | XBI | FBIOX |
|---|---|---|
| Moderna Inc | 1.41% | 1.28% |
| Praxis Precision Medicines Inc | 1.29% | 2.47% |
| Revolution Medicines Inc | 1.20% | 2.02% |
| Natera Inc | 1.16% | 1.41% |
| Scholar Rock Holding Corp | 1.16% | 1.55% |
| Roivant Sciences Ltd | 1.16% | 1.13% |
| Cogent Biosciences Inc | 1.14% | 1.07% |
| Krystal Biotech Inc | 1.10% | 10.58% |
Source: SEC Form N-PORT
XBI top 10
- State Street Global Advisors — 5.87%
- Apogee Therapeutics Inc — 1.49%
- Moderna Inc — 1.41%
- Twist Bioscience Corp — 1.41%
- Oruka Therapeutics Inc — 1.38%
- Kymera Therapeutics Inc — 1.36%
- Viking Therapeutics Inc — 1.30%
- Praxis Precision Medicines Inc — 1.29%
- Erasca Inc — 1.27%
- Revolution Medicines Inc — 1.20%
FBIOX top 10
- Krystal Biotech Inc — 10.58%
- Abbvie Inc — 9.22%
- Amgen Inc — 6.53%
- Gilead Sciences Inc — 4.82%
- Fidelity Revere Street Trust — 3.35%
- Alnylam Pharmaceuticals Inc — 2.93%
- Praxis Precision Medicines Inc. — 2.47%
- Insmed Inc — 2.25%
- Argenx Se — 2.25%
- Ascendis Pharma A/s — 2.04%
FAQ
What is the difference between XBI and FBIOX?
Which is cheaper, XBI or FBIOX?
Should I own both XBI and FBIOX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.